SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the primary analysis of the Phase III HAVEN 7 study reinforced ...
In the second of a series, columnist Joe MacDonald shares how much his sons benefited from learning to administer infusions ...
Hemlibra is a prophylactic (preventative) treatment that can be administered by an injection of a ready-to-use solution under the skin (subcutaneously) once weekly, every two weeks or every four weeks ...
– There is limited information and treatment guidance on moderate and mild hemophilia A, which can lead to delayed or missed diagnoses of bleeding episodes – – Hemlibra is approved to treat people of ...
Hemlibra is a once-weekly injection for patients with hemophilia A who have developed a resistance to other treatments. The drug’s label contains a black box warning over the risk of severe blood ...
When Allison Sandford-Sweatman’s then four-year-old son Griffin was accidentally kicked in the leg by another player, she felt she had no choice but to pull him out of soccer. As a mom to a child with ...
*Based on the STARGLO data, Columvi in combination with GemOx is approved in 49 countries for the treatment of R/R DLBCL including the EU, UK, Australia and Canada. On July 2, 2025, the U.S. Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results